Objective: The objective of the study was to evaluate the dose dependent effects of atorvastatin on rat kidneys. Methods: The selected doses of atorvastatin were administered orally for 17 days to rats. The statin induced nephrotoxicity was accessed by carrying out renal function tests and is by renal histopathology analysis. Measurements of antioxidant enzymes were also carried out to check whether atorvastatin at the selected dose level interfere with any of the antioxidant system. Atorvastatin at three doses 5mg/kg, 10mg/kg and 20mg/kg was tested. Results: Higher doses of atorvastatin exhibits considerable degree of renal toxicity in rats, while the low doses do not interfere with renal functions in rats. Atorvastatin at all the tested d...
In this study, we evaluated the ultrastructural findings of kidney with systemic administration of d...
Cadmium contributes to nephrotoxicity linked with oxidative stress in humans and animals. This study...
BACKGROUND: There is evidence that dyslipidemia is associated with chronic kidney disease (CKD). Exp...
Background and Objectives: Atorvastatin has multiple effects independent of lipid lowering, such as ...
Statins, as the most important cholesterol-lowering agents, inhibit the production of blood choleste...
Background: This study was designed to clarify the toxic effect of a high dose of atorvastatin and t...
Background: Statins are hypocholestrolemic agents used in atherosclerotic vascular disorders. They a...
Objective. Chronic kidney disease (CKD), including nephrotic syndrome, is a major cause of cardiovas...
OBJECTIVE: To investigate the effects of N-acetylcysteine (NAC) and high-dose atorvastatin (ATOR) in...
Introduction: Gentamicin is an aminoglycoside antibiotic that is widely administered to treat s caus...
Background/aim: We aim to determine the effects of low-dose atorvastatin treatment together with cru...
Background: It is well known that the development of brain oxidative stress is one of the most serio...
Copyright © 2012 Ketab E. Al-Otaibi et al. This is an open access article distributed under the Crea...
The data set supports studies involving the protective effect of antioxidants against environmental ...
Statins (atorvastatin) are well known for their lipid lowering potentials and reduction of cardiovas...
In this study, we evaluated the ultrastructural findings of kidney with systemic administration of d...
Cadmium contributes to nephrotoxicity linked with oxidative stress in humans and animals. This study...
BACKGROUND: There is evidence that dyslipidemia is associated with chronic kidney disease (CKD). Exp...
Background and Objectives: Atorvastatin has multiple effects independent of lipid lowering, such as ...
Statins, as the most important cholesterol-lowering agents, inhibit the production of blood choleste...
Background: This study was designed to clarify the toxic effect of a high dose of atorvastatin and t...
Background: Statins are hypocholestrolemic agents used in atherosclerotic vascular disorders. They a...
Objective. Chronic kidney disease (CKD), including nephrotic syndrome, is a major cause of cardiovas...
OBJECTIVE: To investigate the effects of N-acetylcysteine (NAC) and high-dose atorvastatin (ATOR) in...
Introduction: Gentamicin is an aminoglycoside antibiotic that is widely administered to treat s caus...
Background/aim: We aim to determine the effects of low-dose atorvastatin treatment together with cru...
Background: It is well known that the development of brain oxidative stress is one of the most serio...
Copyright © 2012 Ketab E. Al-Otaibi et al. This is an open access article distributed under the Crea...
The data set supports studies involving the protective effect of antioxidants against environmental ...
Statins (atorvastatin) are well known for their lipid lowering potentials and reduction of cardiovas...
In this study, we evaluated the ultrastructural findings of kidney with systemic administration of d...
Cadmium contributes to nephrotoxicity linked with oxidative stress in humans and animals. This study...
BACKGROUND: There is evidence that dyslipidemia is associated with chronic kidney disease (CKD). Exp...